HYDROXYCHLOROQUINE
Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%
The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosystem charge. And both the government and the courts have stepped in. At one level, that is not entirely a bad thing. Check out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focusing on five key components – earnings, fundamentals, relative valuation, risk, and price momentum – to generate standardised scores. SR+ Reports is a complimentary offering to ETPrime members.
When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%
Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends on what it chose in the last five or six. So, one name can do wonderfully while the one sitting next to it does very little. Stock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, fundamentals, relative valuation, risk, and price momentum – to generate standardised scores. The simple average of the above-mentioned five component ratings is normally distributed to reach an average score.
Trump defends use of hydroxychloroquine, says it works in early stages of Covid-19 infection
"I happen to believe in it (hydroxychloroquine). I would take it. As you know, I took it for a 14-day period, and I'm here. I happen to think it works in the early stages. I think frontline medical people believe that too -- some, many," Trump told reporters at a White House news conference on Tuesday.
WHO ending hydroxycholorquine trial for COVID
WHO says a review of the interim results showed hydroxychloroquine and lopinavir/ritonavir "produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care."
How Trump's hydroxychloroquine push became a boon for Ipca Laboratories
The US is still relying on Indian firms to import HCQ even after the drug fell out of favor as a Covid treatment.
Government lifts export ban on anti-malarial drug hydroxychloroquine
"The export policy of Hydroxychloroquine API (active pharmaceutical ingredients) and its formulations from prohibited to free with immediate effect," the Directorate General of Foreign Trade (DFFT) said in a notification.
- Go To Page 1
India lifts export ban on Trump-touted drug hydroxychloroquine
"Department of Pharmaceuticals has approved the lifting of ban on Export of Hydroxychloroquine API as well as formulations," India's minister for chemicals and fertilizers, Sadananda Gowda, said on Twitter.
EU governments ban malaria drug for COVID-19, trial paused as safety fears grow
The moves by France, Italy and Belgium followed a World Health Organization decision on Monday to pause a large trial of hydroxychloroquine due to safety concerns.
Hydroxychloroquine given under supervision, side effects can be addressed, says Indian-American doctor
Considered one of the most influential Indian-American community leaders in the US, Dr Bharat Barai alleged that certain people and media are playing with the lives of the people by not presenting the scientific facts about hydroxychloroquine.
Hydroxychloroquine-azithromycin combo may be potentially lethal: Study
Hydroxychloroquine and azithromycin, alone or in combination, have been proposed for treatment of COVID-19 patients, the researchers said. They explained that reports of potentially lethal acute cardiac proarrhythmogenic effects -- promoting irregular heart rhythms -- have been described mainly with azithromycin but also with hydroxychloroquine.
Lancet study finds no benefit for hydroxychloroquine in COVID-19 patients
The scientists said these drugs should not be used to treat COVID-19 patients outside of clinical trials until results from randomised clinical trials are available to confirm their safety and efficacy for COVID-19 patients. They explained chloroquine, an antimalarial drug and its analogue, hydroxychloroquine, are commonly used to treat autoimmune diseases.
Donald Trump says he is taking unproven drug hydroxychloroquine to ward off coronavirus
The drug has the potential to cause significant side effects in some patients and has not been shown to combat the new coronavirus. Trump said his doctor did not recommend the drug to him, but he requested it from the White House physician.
India exports 50 million hydroxychloroquine tablets to US for COVID-19 fight: Report
The trade, India's biggest export of the drug to any country, follows a request by U.S. President Donald Trump for New Delhi to release supplies of hydroxychloroquine as a possible treatment for the respiratory disease.
COVID-19: FDA warns against side effects of hydroxychloroquine
The US Food and Drug Administration has issued a safety communication regarding the known side effects of anti-malarial drug hydroxychloroquine, touted by President Donald Trump for treating coronavirus patients.
Novartis, U.S. regulators agree to malaria drug hydroxychloroquine trial against COVID-19
Novartis has reached an agreement with U.S. regulators to hold a randomized trial of generic malaria drug hydroxychloroquine against COVID-19 disease in 440 hospitalised patients, the Swiss drugmaker said on Monday.
Bajaj Healthcare gets Gujarat FDA nod to manufacture hydhroxychloroquine sulphate
The company will commence production of hydhroxychloroquine sulphate API in the next 3 weeks at its Vadodara facility and it is estimated to produce 15 Mts of API per month, Bajaj Healthcare said. It has started the production of hydroxychloroquine FDF (tablets) at Vadodara unit and is expected to produce around 1.5 crore hydroxychloroquine sulphate tablets.
India sending hydroxychloroquine to 55 coronavirus-hit countries
Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York.
India agrees to sell hydroxychloroquine to Malaysia to help fight COVID-19
India's decision to sell the sought-after drug to Malaysia signals a turnaround in relations between the countries that had soured because of repeated criticism of some Indian policies by Mahathir Mohamad, before he resigned as Malaysia's prime minister in February.
People pop up, stock hydroxychloroquine; Gujarat govt intervenes
Touted as 'game changer' in the fight against coronavirus, Hydroxychloroquine's demand has increased after US President Donald Trump requested the Indian government to allow its export to America to treat COVID-19 patients. However, authorities have warned that self-medication can cause harm and side effects if not taken under proper care of doctors.
Hydroxychloroquine consignment from India arrives in US
Earlier this week, India at the request of President Donald Trump cleared the export of 35.82 lakh tablets of hydroxychloroquine to the US along with nine metric tons of active pharmaceutical ingredient or API required in the manufacturing of the drug.
Shipment of hydroxychloroquine to US likely to start next week: IPA
"The shipments of hydroxychloroquine to the US are likely to start next week. Indian pharma companies are committed to meet both, domestic and export commitments," Indian Pharmaceutical Alliance Secretary General Sudarshan Jain said. This is in line with India's role as pharmacy of the world, he added.
Government decides to export surplus hydroxychloroquine, says there is buffer stock for India
Addressing a briefing, MEA Additional Secretary Dammu Ravi, who is also the COVID-19 coordinator, said that hydroxychloroquine is in high demand globally and a decision for exporting the drug to the first list of countries which put in a request has been approved.
Enough stock of hydroxychloroquine in India: Govt
"There is enough stock of hydroxychloroquine in the country and we are tracking its demand, availability and production on a daily basis," National Pharmaceutical Pricing Authority (NPPA) Chairman Shubhra Singh said.
India to export hydroxychloroquine only to foreign governments and not to private companies: Sources
"Hydroxychloroquine continues to be a prohibited item. Private-to-private company or a domestic exporter-to-foreign importer trade is ban. The procedure, which the government is adopting, is to help countries which are in dire need or which are traditionally dependent on India for this medicine or friendly countries like Nepal, Sri Lanka and Bhutan," the sources said.
PM Modi was 'terrific' in allowing export of hydroxychloroquine to US: Donald Trump
US President Donald Trump on Wednesday thanked India for PM Narendra Modi's decision to allow the export of malaria drug Hydroxychloroquine to the United States.
Gujarat companies to export hydroxychloroquine to US: Vijay Rupani
Hydroxychloroquine is an old and inexpensive drug used to treat malaria, the export of which was banned by India last month amid views that it could be used as potential anti-viral agent to protect from infection healthcare workers treating coronavirus patients.
Trump seeks Modi's help to release Hydroxychloroquine ordered by US to treat COVID-19 patients
India on April 4 banned the export of Hydroxychloroquine and its formulations with immediate effect.
Blanket ban on export of anti-malarial drug hydroxychloroquine, government withdraws exemptions
However, the directorate amended the policy on Saturday and withdrew these exemptions, saying that the export of Hydroxychloroquine and formulations made from Hydroxychloroquine is no longer allowed from SEZs/EOUs or against Advance Authorisation or against full advance payment.
Intas to provide 2 million hydroxychloroquine tablets for WHO study on COVID-19
Intas informed that it is collaborating on the WHO-endorsed study using hydroxychloroquine, a drug that may have an effect in preventing and/or reducing symptoms of COVID-19. The global COPCOV (chloroquine / hydroxychloroquine prevention of COVID-19 in the healthcare setting; a randomised, placebo-controlled prophylaxis).
Load More
